{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T19:12:11Z","timestamp":1791400331708,"version":"4.3.3"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T00:00:00Z","timestamp":1745452800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"JSPS KAKENHI","award":["JP22K16073"],"award-info":[{"award-number":["JP22K16073"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Aims<\/jats:title>\n                  <jats:p>The pharmacological effect of direct oral anticoagulants (DOACs) is influenced by binding status with albumin. This study aimed to assess the association between albumin levels and bleeding risk in atrial fibrillation (AF) patients treated with DOACs.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and results<\/jats:title>\n                  <jats:p>We conducted DIRECT-Extend registry (N = 7512), a pooled database combining three large-scale observational study of AF patients treated with DOAC. The primary endpoint was major bleeding as defined by International Society on Thrombosis and Haemostasis criteria. Multivariable Cox hazard model was used to assess the impact of albumin level on major bleeding. Out of the overall cohort, 2523 patients [73 (IQR 66\u201380) years, 1620 (64.2%) males] with albumin data available at enrolment were analyzed in this study. Median follow-up duration was 532 days (IQR 94\u20131405 days). The entire cohort was divided into tertiles based on albumin levels (lower tertile: &amp;lt;3.7\u2005g\/dL, middle tertile: 3.7\u20134.1\u2005g\/dL, and higher tertile: \u22654.1\u2005g\/dL). The incidences of major bleeding increased as albumin levels decreased; 56 patients (6.8%), 81 patients (9.7%), and 113 patients (13.1%) in the higher, middle, and lower tertiles, respectively. (Log-rank test P &amp;lt; 0.0001). A lower albumin level was independently associated with a higher incidence of major bleeding (adjusted hazard ratio 0.61, 95% confidence interval 0.47\u20130.80, P &amp;lt; 0.01), which was consistently observed in all DOACs (P-value for interaction &amp;gt;0.05).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>A lower albumin level was independently associated with a higher bleeding risk in AF patients using DOACs. Careful attention should be paid to hypoalbuminemia when prescribing DOACs.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ehjcvp\/pvaf030","type":"journal-article","created":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T07:43:33Z","timestamp":1745394213000},"page":"422-432","source":"Crossref","is-referenced-by-count":6,"title":["Albumin level and risk of major bleeding in patients with atrial fibrillation on direct oral anticoagulants"],"prefix":"10.1093","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9561-0201","authenticated-orcid":false,"given":"Shun","family":"Sasaki","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine , 2-2 Yamadaoka, Suita, Osaka 565-0871 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Sakamoto","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine , 2-2 Yamadaoka, Suita, Osaka 565-0871 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Matsuoka","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine , 2-2 Yamadaoka, Suita, Osaka 565-0871 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1725-781X","authenticated-orcid":false,"given":"Katsuki","family":"Okada","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine , 2-2 Yamadaoka, Suita, Osaka 565-0871 ,","place":["Japan"]},{"name":"Department of Medical Informatics, Osaka University Graduate School of Medicine , 2-2 Yamadaoka, Suita, Osaka 565-0871 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Sunaga","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine , 2-2 Yamadaoka, Suita, Osaka 565-0871 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1534-2033","authenticated-orcid":false,"given":"Daisaku","family":"Nakatani","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine , 2-2 Yamadaoka, Suita, Osaka 565-0871 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidetaka","family":"Kioka","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine , 2-2 Yamadaoka, Suita, Osaka 565-0871 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Kanda","sequence":"additional","affiliation":[{"name":"Cardiovascular Division, Osaka Keisatsu Hospital , 2-6-40 Karasugatsuji, Tennoji-ku, Osaka 543-8922 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3319-6316","authenticated-orcid":false,"given":"Hitoshi","family":"Minamiguchi","sequence":"additional","affiliation":[{"name":"Cardiovascular Division, Osaka Keisatsu Hospital , 2-6-40 Karasugatsuji, Tennoji-ku, Osaka 543-8922 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuta","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Nihon University School of Medicine , 30-1 Oyaguchi-kamicho, Itabashi-ku, Tokyo 173-8610 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kouichi","family":"Nagashima","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Nihon University School of Medicine , 30-1 Oyaguchi-kamicho, Itabashi-ku, Tokyo 173-8610 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiharu","family":"Higuchi","sequence":"additional","affiliation":[{"name":"Cardiovascular Division, Osaka Keisatsu Hospital , 2-6-40 Karasugatsuji, Tennoji-ku, Osaka 543-8922 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2960-4241","authenticated-orcid":false,"given":"Yasuo","family":"Okumura","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Nihon University School of Medicine , 30-1 Oyaguchi-kamicho, Itabashi-ku, Tokyo 173-8610 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7564-2978","authenticated-orcid":false,"given":"Yohei","family":"Sotomi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine , 2-2 Yamadaoka, Suita, Osaka 565-0871 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Sakata","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine , 2-2 Yamadaoka, Suita, Osaka 565-0871 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,4,24]]},"reference":[{"key":"2025081219533972600_pvaf030-B1","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"key":"2025081219533972600_pvaf030-B2","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1253\/circj.CJ-20-1212","article-title":"JCS\/JHRS 2020 guideline on pharmacotherapy of cardiac arrhythmias","volume":"86","author":"Ono","year":"2022","journal-title":"Circ J"},{"key":"2025081219533972600_pvaf030-B3","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1161\/cir.0000000000001193","article-title":"2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines","volume":"149","author":"Joglar","year":"2024","journal-title":"Circulation"},{"key":"2025081219533972600_pvaf030-B4","doi-asserted-by":"publisher","first-page":"e2877","DOI":"10.1002\/jmr.2877","article-title":"Binding of direct oral anticoagulants to the FA1 site of human serum albumin","volume":"34","author":"De Simone","year":"2021","journal-title":"J Mol Recognit"},{"key":"2025081219533972600_pvaf030-B5","doi-asserted-by":"publisher","first-page":"684638","DOI":"10.3389\/fphar.2021.684638","article-title":"Direct oral anticoagulants: from randomized clinical trials to real-world clinical practice","volume":"12","author":"Roberti","year":"2021","journal-title":"Front Pharmacol"},{"key":"2025081219533972600_pvaf030-B6","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1177\/0310057x8301100407","article-title":"Pharmacokinetics in renal failure","volume":"11","author":"Nancarrow","year":"1983","journal-title":"Anaesth Intensive Care"},{"key":"2025081219533972600_pvaf030-B7","doi-asserted-by":"publisher","first-page":"3331","DOI":"10.1016\/j.xphs.2021.05.018","article-title":"Impact of changes in free concentrations and drug-protein binding on drug dosing regimens in special populations and disease states","volume":"110","author":"Celestin","year":"2021","journal-title":"J Pharm Sci"},{"key":"2025081219533972600_pvaf030-B8","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1093\/bja\/85.4.599","article-title":"The role of albumin in critical illness","volume":"85","author":"Nicholson","year":"2000","journal-title":"Br J Anaesth"},{"key":"2025081219533972600_pvaf030-B9","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the euro heart survey","volume":"138","author":"Pisters","year":"2010","journal-title":"Chest"},{"key":"2025081219533972600_pvaf030-B10","doi-asserted-by":"publisher","first-page":"3258","DOI":"10.1093\/eurheartj\/ehv476","article-title":"The ORBIT bleeding score: a simple bedside score to assess bleeding risk in atrial fibrillation","volume":"36","author":"O'Brien","year":"2015","journal-title":"Eur Heart J"},{"key":"2025081219533972600_pvaf030-B11","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1161\/circulationaha.123.064556","article-title":"Development and validation of the DOAC score: a novel bleeding risk prediction tool for patients with atrial fibrillation on direct-acting oral anticoagulants","volume":"148","author":"Aggarwal","year":"2023","journal-title":"Circulation"},{"key":"2025081219533972600_pvaf030-B12","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.amjcard.2021.09.019","article-title":"Comparison of low-dose direct oral anticoagulants for patients &lt;80 versus &gt;\/=80 years of age with atrial fibrillation","volume":"162","author":"Sasaki","year":"2022","journal-title":"Am J Cardiol"},{"key":"2025081219533972600_pvaf030-B13","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.joa.2016.11.003","article-title":"Current use of direct oral anticoagulants for atrial fibrillation in Japan: findings from the SAKURA AF registry","volume":"33","author":"Okumura","year":"2017","journal-title":"J Arrhythm"},{"key":"2025081219533972600_pvaf030-B14","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients","volume":"3","author":"Schulman","year":"2005","journal-title":"J Thromb Haemost"},{"key":"2025081219533972600_pvaf030-B15","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1111\/jth.13140","article-title":"Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH","volume":"13","author":"Kaatz","year":"2015","journal-title":"J Thromb Haemost"},{"key":"2025081219533972600_pvaf030-B16","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1161\/circulationaha.114.013243","article-title":"Extracranial systemic embolic events in patients with nonvalvular atrial fibrillation: incidence, risk factors, and outcomes","volume":"132","author":"Bekwelem","year":"2015","journal-title":"Circulation"},{"key":"2025081219533972600_pvaf030-B17","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1093\/bioinformatics\/btr597","article-title":"MissForest\u2013non-parametric missing value imputation for mixed-type data","volume":"28","author":"Stekhoven","year":"2012","journal-title":"Bioinformatics"},{"key":"2025081219533972600_pvaf030-B18","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1253\/circj.CJ-19-1006","article-title":"Persistent systemic inflammation is associated with bleeding risk in atrial fibrillation patients","volume":"84","author":"Hamanaka","year":"2020","journal-title":"Circ J"},{"key":"2025081219533972600_pvaf030-B19","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"key":"2025081219533972600_pvaf030-B20","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1007\/s11239-020-02092-w","article-title":"Albumin and bleed risk in rivaroxaban treated patients","volume":"50","author":"Wojakowski","year":"2020","journal-title":"J Thromb Thrombolysis"},{"key":"2025081219533972600_pvaf030-B21","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ijcha.2019.01.002","article-title":"Impact of serum albumin levels on supratherapeutic PT-INR control and bleeding risk in atrial fibrillation patients on warfarin: a prospective cohort study","volume":"22","author":"Kawai","year":"2019","journal-title":"Int J Cardiol Heart Vasc"},{"key":"2025081219533972600_pvaf030-B22","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1016\/j.clinthera.2009.07.015","article-title":"Anemia, hypoalbuminemia, and renal impairment as predictors of bleeding complications in patients receiving anticoagulation therapy for nonvalvular atrial fibrillation: a secondary analysis","volume":"31","author":"Abdelhafiz","year":"2009","journal-title":"Clin Ther"},{"key":"2025081219533972600_pvaf030-B23","doi-asserted-by":"publisher","first-page":"100203","DOI":"10.1016\/j.ahjo.2022.100203","article-title":"Twice- or once-daily dosing of direct oral anticoagulants and gastrointestinal bleeding in patient with atrial fibrillation","volume":"22","author":"Ido","year":"2022","journal-title":"Am Heart J Plus"},{"key":"2025081219533972600_pvaf030-B24","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1001\/jama.2021.21222","article-title":"Association of rivaroxaban vs apixaban with major ischemic or hemorrhagic events in patients with atrial fibrillation","volume":"326","author":"Ray","year":"2021","journal-title":"JAMA"},{"key":"2025081219533972600_pvaf030-B25","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.3748\/wjg.v23.i11.1954","article-title":"Gastrointestinal bleeding in patients on novel oral anticoagulants: risk, prevention and management","volume":"23","author":"Cheung","year":"2017","journal-title":"World J Gastroenterol"}],"container-title":["European Heart Journal - Cardiovascular Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjcvp\/advance-article-pdf\/doi\/10.1093\/ehjcvp\/pvaf030\/63001924\/pvaf030.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcvp\/article-pdf\/11\/5\/422\/63001924\/pvaf030.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcvp\/article-pdf\/11\/5\/422\/63001924\/pvaf030.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T23:53:48Z","timestamp":1755042828000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjcvp\/article\/11\/5\/422\/8119318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,24]]},"references-count":25,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,4,24]]},"published-print":{"date-parts":[[2025,8,12]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjcvp\/pvaf030","relation":{},"ISSN":["2055-6837","2055-6845"],"issn-type":[{"value":"2055-6837","type":"print"},{"value":"2055-6845","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,8]]},"published":{"date-parts":[[2025,4,24]]}}}